*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Morgan Stanley upped its rating on shares of credit-checking firm Experian to ‘overweight’ from ‘equalweight’ on Wednesday as it pointed to a change in regulation in Brazil that should benefit the group.
Morgan Stanley upped its rating on shares of credit-checking firm Experian to ‘overweight’ from ‘equalweight’ on Wednesday as it pointed to a change in regulation in Brazil that should benefit the group.
Analysts at Berenberg cut their target price on 'hold' rated N Brown on Wednesday, saying the retailer's operational performance over the last few months was not going "in the same direction" as it had when the firm's strong run began at the start of 2019.
Jefferies downgraded its stance on shares of private healthcare provider Spire Healthcare to ‘underperform’ on Tuesday, as it said the rally since 3 October, when it upgraded to ‘hold’, gives an "unfavourable risk/reward" to the stock.
JPMorgan Cazenove downgraded its stance on shares of posh tonics maker Fevertree to ‘neutral’ from ‘overweight’ on Tuesday and slashed the price target to 1,500p from 2,400p following the company’s second profit warning in two months.
Jefferies downgraded its stance on shares of private healthcare provider Spire Healthcare to ‘underperform’ on Tuesday, as it said the rally since 3 October, when it upgraded to ‘hold’, gives an "unfavourable risk/reward" to the stock.
Morgan Stanley downgraded shares of online fashion retailer ASOS to ‘underweight’ from ‘equalweight’ on Monday, cutting the price target to 2,000p from 2,100p as it argued that consensus medium-term forecasts are "still much too high".
Morgan Stanley downgraded shares of online fashion retailer ASOS to ‘underweight’ from ‘equalweight’ on Monday, cutting the price target to 2,000p from 2,100p as it argued that consensus medium-term forecasts are "still much too high".
Analysts at Credit Suisse started coverage of London-listed Russian natural gas giant Gazprom a 'neutral' with a $9. 0 target price on its American Depositary Receipts, forecasting that the group's payout policy would rise to 5. 0% of profits by 2021, versus 30. 0% in 2019.
JPMorgan Cazenove downgraded its stance on shares of medical products maker ConvaTec to ‘underweight’ from ‘neutral’ on Monday, cutting the price target to 168p from 171p as it pointed to an unattractive risk/reward.
Analysts at Canaccord Genuity lowered their target price on Premier Inn operator Whitbread to 4,250p from 4,500p on Friday following the group's "disappointing" third-quarter update in the previous session.
Analysts at Morgan Stanley reiterated their 'equalweight' recommendation for shares of Tullow Oil, telling clients that its most recent guidance left key questions unanswered.
Analysts at Morgan Stanley upgraded Ashtead to 'overweight' on Friday, stating that data centres were an "overlooked structural growth opportunity" for US construction equipment rental.
Analysts at Canaccord Genuity lowered their target price on Premier Inn operator Whitbread to 4,250p from 4,500p on Friday following the group's "disappointing" third-quarter update in the previous session.
